| Jul 30 |
InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases
|
| Jun 24 |
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|
| Jun 24 |
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
|
| Jun 5 |
InflaRx Hosts R&D Event Highlighting the Promise of INF904
|
| May 21 |
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
|
